2023 Assisted Circulation Gordon Research Conference and Seminar
2023 Assisted Circulation Gordon Research Conference and Seminar
批准号:
10682886
负责人:
Kurt A Dasse
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-05-17 至 2024-04-30
关键词:
AcademiaAcademic supportAccelerationAddressAdverse eventAreaAssisted CirculationBasic ScienceBudgetsCardiacCaringClinicalCollaborationsCommunitiesConsensusDataDevelopmentDevice DesignsDevicesDisciplineEngineeringEthnic OriginFundingFutureGenderGeographyGoalsGovernmentHealth PersonnelHealthcareHeart TransplantationHeart failureHemorrhageHospitalsHuman BiologyIndustryInfectionInstitutionInternationalLifeMedicalMedicineMentorsMethodologyMethodsMonitorNew HampshireOrgan DonorParticipantPatient-Focused OutcomesPatientsPharmaceutical PreparationsPreparationPrevalenceProblem SolvingPrognosisQuality of lifeRecoveryRefractoryResearchResearch PersonnelResourcesRewardsScienceScientistSummary ReportsSurveysTechnologyThinkingThrombusTranslatingTranslational ResearchTransplantationTravelUnderrepresented MinorityWomanadjudicationblood damagecareerclinical investigationclinical practiceclinical translationclinically significantcostdata sharingdesignevidence baseexperiencefollow-upimprovedimproved outcomeinnovationintervention costmechanical circulatory supportmeetingsminority childrenminority scientistmultidisciplinarynovelpatient populationpharmacologicpostoperative recoveryprogramsprospectiveresearch and developmentsuccesssymposiumtooltranslational approach
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary – The Gordon Research Conference (GRC) on Assisted Circulation is a bi-annual meeting
consisting of a diverse group of invited speakers, discussion leaders, and participants who are internationally-
recognized clinicians, engineers, and scientists pioneering the field of mechanical circulatory support (MCS)
and related disciplines. Our GRC program committee has developed a one-week program in preparation for
our next GRC on Assisted Circulation to be held in in Waterville Valley, New Hampshire from May 28 - June 2,
2023. The focus of our comprehensive GRC program is on the latest emerging developments in the MCS
field, including the presentation of previously unpublished data, clinical and scientific evidence-based research
and development activities, and introducing novel concepts that impact the future of MCS therapy and are
designed to improve heart failure (HF) patient outcomes and restore their quality of life. Invited speakers are
pioneers in the MCS field and related disciplines that will present their ground-breaking research and
development in critical areas of need. Discussion leaders will promote and actively engage audience
participation to encourage open and interactive exchange of concepts and ideas that are provocative and
stimulating to facilitate and rapidly accelerate advancement of MCS therapy. GRC participants will be
comprised of multi-disciplinary (clinical, engineering, science), multi-institutional (academic, industry, hospital,
government), and multi-diversity (career-stage, ethnic, gender, geographical) participants adjudicated by GRC
and Program Committee to be inclusive and representative of wide-range of experience, expertise, ideas, and
unbiased prospective. Our GRC program committee is requesting supplemental funding ($10,000 budget),
specifically to support travel-related expenses for ten early-stage invited speakers of diverse background
(women and/or non-white) in the MCS field or related discipline. The primary goal of the GRC on Assisted
Circulation will be to address and achieve each of the following objectives: (1) identify best clinical practices
and provide inventive methods to achieve consensus and harmonize best practices among MCS centers and
health care providers; (2) review the latest advancements in novel MCS device technologies that represent
disruptive or revolutionary ideas in the field as well as highlight a "conceptual thinking" session, where GRC
participants can contribute to the development of novel device designs or innovative ways of problem solving;
and (3) highlight novel basic science discoveries and innovative methods to translate these discoveries into
best practices, including human biology and the changes and adaptation of the human biology associated with
the presence of MCS device therapy. GRC surveys will be completed by all attendees (invited speakers,
discussion leaders, participants) to assess program quality and whether objectives were successfully met, and
the program committee will complete a summary report highlighting critical areas of need and establishing Best
Practices criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants
-
批准号:10547304
-
项目类别:
-
资助金额:$100.26万
-
财政年份:2018
-
负责人:Kurt A Dasse
-
依托单位:
海外基金